ピモジド錠剤の世界市場レポート 2025年

ピモジド錠剤市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.6％で26億6,000万米ドルに成長します。予測期間の成長は、メンタルヘルスサービスへのアクセスの改善、可処分所得の増加、精神障害治療薬のジェネリック医薬品の参入、新たな規制当局の承認とラベルの拡大、副作用の管理と軽減の改善に起因すると考えられます。予測期間における主な動向としては、技術の進歩、eコマース・プラットフォームの台頭、精神疾患の診断技術の進歩、新興国での市場浸透、遠隔医療やオンライン診察の拡大などが挙げられます。

精神疾患の有病率の増加は、今後のピモジド錠剤市場の成長を牽引すると予想されます。精神疾患とは、思考、感情、行動に著しい障害があり、苦痛や機能障害につながる精神衛生状態を指します。精神疾患の有病率上昇の要因としては、ストレスレベルの上昇、社会規範の進化、認知度の向上と診断の改善、遺伝的素因などが挙げられます。ピモジド錠は、妄想やチックなどの症状を管理し、脳の異常な活動を抑えるためにドーパミン受容体を遮断することで作用するため、精神疾患の治療によく使用されます。例えば、2022年2月、スイスを拠点とする市民社会ネットワークであるNCDアライアンスは、世界で5,500万人が認知症を患っており、毎年1,000万人近くが新たに認知症と診断されていると報告しました。この数字は2030年までに約7,500万人、2050年までに1億3,900万人に増加すると予想されています。その結果、精神疾患の有病率の増加がピモジド錠剤の需要に拍車をかけています。

ヘルスケア支出の増加がピモジド錠剤市場の成長を促進すると予想されます。ヘルスケア支出は、先進医療技術にかかる費用の増加、人口の高齢化、慢性疾患の蔓延などにより増加しています。こうした支出の増加は、精神科治療へのアクセスを向上させ、精神科治療薬の保険適用範囲を広げ、ピモジド錠剤の需要を促進しています。例えば、米国の政府機関である国立衛生研究所（National Institutes of Health）は2024年1月に、米国の医療費は2022年に4.1%増加し、4兆5,000億米ドルに達したと報告しました。その結果、ヘルスケア支出の増加がピモジド錠剤市場の成長に寄与しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界ピモジド錠剤PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のピモジド錠剤市場：成長率分析
• 世界のピモジド錠剤市場の実績：規模と成長, 2019-2024
• 世界のピモジド錠剤市場の予測：規模と成長, 2024-2029, 2034F
• 世界ピモジド錠剤総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のピモジド錠剤市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 1ミリグラム
• 2ミリグラム
• 4ミリグラム
• 世界のピモジド錠剤市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オンライン
• オフライン
• 世界のピモジド錠剤市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• トゥレット症候群
• 慢性統合失調症
• 世界のピモジド錠剤市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• 家庭用
• 世界のピモジド錠剤市場1ミリグラムのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ボトル包装
• ブリスター包装
• 単位用量包装
• 世界のピモジド錠剤市場2ミリグラムのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ボトル包装
• ブリスター包装
• 単位用量包装
• 世界のピモジド錠剤市場4ミリグラムのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ボトル包装
• ブリスター包装
• 単位用量包装

第7章 地域別・国別分析

• 世界のピモジド錠剤市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のピモジド錠剤市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ピモジド錠剤市場：競合情勢
• ピモジド錠剤市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Bristol-Myers Squibb Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• GlaxoSmithKline plc
• C.H. Boehringer Sohn AG & Co. KG
• Teva Pharmaceutical Industries Ltd.
• Hetero Drugs
• Sun Pharmaceutical Industries Ltd.
• Jazz Pharmaceuticals
• Aurobindo Pharma
• Cipla Limited
• Apotex Inc.
• H. Lundbeck A/S
• Dr. Reddy's Laboratories
• Hikma Pharmaceuticals
• Amneal Pharmaceuticals
• Endo International
• Lupin Limited

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ピモジド錠剤市場2029：新たな機会を提供する国
• ピモジド錠剤市場2029：新たな機会を提供するセグメント
• ピモジド錠剤市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Pimozide tablets are antipsychotic drugs mainly prescribed for managing Tourette's syndrome and chronic psychosis. They function by inhibiting dopamine receptors in the brain, which helps alleviate symptoms such as tics and hallucinations. These tablets are usually recommended when other treatments have failed.

Pimozide tablets are available in 1 milligram, 2 milligrams, and 4 milligrams. The 1 mg tablets contain pimozide as the active ingredient, along with calcium stearate, microcrystalline cellulose, lactose anhydrous, and corn starch as inactive ingredients. They are distributed through both online and offline channels and are used for treating Tourette's syndrome and chronic schizophrenia. The tablets are utilized by various end users, including hospitals, clinics, and individuals for home use.

The pimozide tablets market research report is one of a series of new reports from The Business Research Company that provides pimozide tablets market statistics, including pimozide tablets industry global market size, regional shares, competitors with a pimozide tablets market share, detailed pimozide tablets market segments, market trends and opportunities, and any further data you may need to thrive in the pimozide tablets industry. This pimozide tablets market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pimozide tablet market size has grown strongly in recent years. It will grow from $1.67 $ billion in 2024 to $1.84 $ billion in 2025 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to increased diagnosis rates of mental disorders, rise in mental health awareness, improved insurance coverage, improved healthcare infrastructure, and an increasing geriatric population.

The pimozide tablet market size is expected to see strong growth in the next few years. It will grow to $2.66 $ billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to improved access to mental health services, rising disposable incomes, entry of generic versions of mental disorder drugs, new regulatory approvals and label expansions, and improved management and reduction of side effects. Major trends in the forecast period include technological advancements, the rise of e-commerce platforms, advances in diagnostic techniques for psychiatric disorders, market penetration in emerging economies, and the growth of telemedicine and online consultations.

The increasing prevalence of psychiatric disorders is expected to drive the growth of the pimozide tablet market in the future. Psychiatric disorders refer to mental health conditions marked by significant disturbances in thoughts, emotions, or behaviors, which lead to distress or impaired functioning. Factors contributing to the rising prevalence of psychiatric disorders include elevated stress levels, evolving societal norms, greater awareness and improved diagnosis, and genetic predispositions. Pimozide tablets are commonly used in treating psychiatric disorders by managing symptoms such as delusions and tics, as they work by blocking dopamine receptors to help reduce abnormal brain activity. For example, in February 2022, the NCD Alliance, a Switzerland-based civil society network, reported that 55 million people worldwide are living with dementia, with nearly 10 million new cases diagnosed annually. This figure is expected to rise to approximately 75 million by 2030 and 139 million by 2050. Consequently, the growing prevalence of psychiatric disorders is fueling the demand for pimozide tablets.

The rise in healthcare expenditure is expected to fuel the growth of the pimozide tablet market. Healthcare spending is increasing due to higher costs for advanced medical technologies, an aging population, and the prevalence of chronic diseases. This increased expenditure enhances access to mental health treatments and broadens insurance coverage for psychiatric medications, driving demand for pimozide tablets. For example, the National Institutes of Health, a US-based government agency, reported in January 2024 that healthcare expenditure in the US grew by 4.1% in 2022, reaching $4.5 trillion, a notable increase from the 3.2% growth observed in 2021. Consequently, rising healthcare spending is contributing to the growth of the pimozide tablet market.

In April 2022, Saladax Biomedical Inc., a US-based medical laboratory, acquired a patent portfolio for antipsychotic drug testing from Janssen Pharmaceutica NV for an undisclosed amount. This acquisition positions Saladax as a prominent player in the antipsychotic drug testing field, enhancing its capabilities in therapeutic drug monitoring (TDM) for major antipsychotic medications used globally. Janssen Pharmaceutica NV, based in Belgium, is a provider of antipsychotic drugs, including pimozide.

Major companies operating in the pimozide tablet market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Bristol-Myers Squibb, GlaxoSmithKline plc, C.H. Boehringer Sohn AG & Co. KG, Teva Pharmaceutical Industries Ltd., Hetero Drugs, Sun Pharmaceutical Industries Ltd., Jazz Pharmaceuticals, Aurobindo Pharma, Cipla Limited, Apotex Inc., H. Lundbeck A/S, Dr. Reddy's Laboratories, Hikma Pharmaceuticals, Amneal Pharmaceuticals, Endo International, Lupin Limited, Zydus Cadila, Alkem Laboratories, Torrent Pharmaceuticals, Glenmark Pharmaceuticals, Mallinckrodt Pharmaceuticals, Jubilant Life Sciences, Alembic Pharmaceuticals, Wockhardt, AA Pharma, Taj Pharmaceuticals

North America was the largest region in the pimozide tablet market in 2023. The regions covered in the pimozide tablet market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pimozide tablet market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pimozide tablet market consists of sales of orap, orap forte, and opiran. The market value includes the value of related goods sold by the service provider or included within the service offering. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pimozide Tablet Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pimozide tablet market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pimozide tablet ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pimozide tablet market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: 1 Milligram; 2 Milligram; 4 Milligram
• 2) By Distribution Channel: Online; Offline
• 3) By Application: Tourette's Syndrome; Chronic Schizophrenia
• 4) By End User: Hospitals; Clinics; Home Use
• Subsegments:
• 1) By 1 Milligram: Bottle Packaging; Blister Packaging; Unit Dose Packaging
• 2) By 2 Milligram: Bottle Packaging; Blister Packaging; Unit Dose Packaging
• 3) By 4 Milligram: Bottle Packaging; Blister Packaging; Unit Dose Packaging
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; AbbVie Inc.; Novartis AG; Bristol-Myers Squibb
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pimozide Tablet Market Characteristics

3. Pimozide Tablet Market Trends And Strategies

4. Pimozide Tablet Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Pimozide Tablet Growth Analysis And Strategic Analysis Framework

• 5.1. Global Pimozide Tablet PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Pimozide Tablet Market Growth Rate Analysis
• 5.4. Global Pimozide Tablet Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Pimozide Tablet Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Pimozide Tablet Total Addressable Market (TAM)

6. Pimozide Tablet Market Segmentation

• 6.1. Global Pimozide Tablet Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 1 Milligram
• 2 Milligram
• 4 Milligram
• 6.2. Global Pimozide Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Online
• Offline
• 6.3. Global Pimozide Tablet Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tourette's Syndrome
• Chronic Schizophrenia
• 6.4. Global Pimozide Tablet Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Home Use
• 6.5. Global Pimozide Tablet Market, Sub-Segmentation Of 1 Milligram, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bottle Packaging
• Blister Packaging
• Unit Dose Packaging
• 6.6. Global Pimozide Tablet Market, Sub-Segmentation Of 2 Milligram, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bottle Packaging
• Blister Packaging
• Unit Dose Packaging
• 6.7. Global Pimozide Tablet Market, Sub-Segmentation Of 4 Milligram, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bottle Packaging
• Blister Packaging
• Unit Dose Packaging

7. Pimozide Tablet Market Regional And Country Analysis

• 7.1. Global Pimozide Tablet Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Pimozide Tablet Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pimozide Tablet Market

• 8.1. Asia-Pacific Pimozide Tablet Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pimozide Tablet Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Pimozide Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Pimozide Tablet Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pimozide Tablet Market

• 9.1. China Pimozide Tablet Market Overview
• 9.2. China Pimozide Tablet Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Pimozide Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Pimozide Tablet Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pimozide Tablet Market

• 10.1. India Pimozide Tablet Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Pimozide Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Pimozide Tablet Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pimozide Tablet Market

• 11.1. Japan Pimozide Tablet Market Overview
• 11.2. Japan Pimozide Tablet Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Pimozide Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Pimozide Tablet Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pimozide Tablet Market

• 12.1. Australia Pimozide Tablet Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Pimozide Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Pimozide Tablet Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pimozide Tablet Market

• 13.1. Indonesia Pimozide Tablet Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Pimozide Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Pimozide Tablet Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pimozide Tablet Market

• 14.1. South Korea Pimozide Tablet Market Overview
• 14.2. South Korea Pimozide Tablet Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Pimozide Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Pimozide Tablet Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pimozide Tablet Market

• 15.1. Western Europe Pimozide Tablet Market Overview
• 15.2. Western Europe Pimozide Tablet Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Pimozide Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Pimozide Tablet Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pimozide Tablet Market

• 16.1. UK Pimozide Tablet Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Pimozide Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Pimozide Tablet Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pimozide Tablet Market

• 17.1. Germany Pimozide Tablet Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Pimozide Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Pimozide Tablet Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pimozide Tablet Market

• 18.1. France Pimozide Tablet Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Pimozide Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Pimozide Tablet Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pimozide Tablet Market

• 19.1. Italy Pimozide Tablet Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Pimozide Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Pimozide Tablet Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pimozide Tablet Market

• 20.1. Spain Pimozide Tablet Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Pimozide Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Pimozide Tablet Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pimozide Tablet Market

• 21.1. Eastern Europe Pimozide Tablet Market Overview
• 21.2. Eastern Europe Pimozide Tablet Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Pimozide Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Pimozide Tablet Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pimozide Tablet Market

• 22.1. Russia Pimozide Tablet Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Pimozide Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Pimozide Tablet Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pimozide Tablet Market

• 23.1. North America Pimozide Tablet Market Overview
• 23.2. North America Pimozide Tablet Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Pimozide Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Pimozide Tablet Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pimozide Tablet Market

• 24.1. USA Pimozide Tablet Market Overview
• 24.2. USA Pimozide Tablet Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Pimozide Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Pimozide Tablet Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pimozide Tablet Market

• 25.1. Canada Pimozide Tablet Market Overview
• 25.2. Canada Pimozide Tablet Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Pimozide Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Pimozide Tablet Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pimozide Tablet Market

• 26.1. South America Pimozide Tablet Market Overview
• 26.2. South America Pimozide Tablet Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Pimozide Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Pimozide Tablet Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pimozide Tablet Market

• 27.1. Brazil Pimozide Tablet Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Pimozide Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Pimozide Tablet Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pimozide Tablet Market

• 28.1. Middle East Pimozide Tablet Market Overview
• 28.2. Middle East Pimozide Tablet Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Pimozide Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Pimozide Tablet Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pimozide Tablet Market

• 29.1. Africa Pimozide Tablet Market Overview
• 29.2. Africa Pimozide Tablet Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Pimozide Tablet Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Pimozide Tablet Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pimozide Tablet Market Competitive Landscape And Company Profiles

• 30.1. Pimozide Tablet Market Competitive Landscape
• 30.2. Pimozide Tablet Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bristol-Myers Squibb Overview, Products and Services, Strategy and Financial Analysis

31. Pimozide Tablet Market Other Major And Innovative Companies

• 31.1. GlaxoSmithKline plc
• 31.2. C.H. Boehringer Sohn AG & Co. KG
• 31.3. Teva Pharmaceutical Industries Ltd.
• 31.4. Hetero Drugs
• 31.5. Sun Pharmaceutical Industries Ltd.
• 31.6. Jazz Pharmaceuticals
• 31.7. Aurobindo Pharma
• 31.8. Cipla Limited
• 31.9. Apotex Inc.
• 31.10. H. Lundbeck A/S
• 31.11. Dr. Reddy's Laboratories
• 31.12. Hikma Pharmaceuticals
• 31.13. Amneal Pharmaceuticals
• 31.14. Endo International
• 31.15. Lupin Limited

32. Global Pimozide Tablet Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pimozide Tablet Market

34. Recent Developments In The Pimozide Tablet Market

35. Pimozide Tablet Market High Potential Countries, Segments and Strategies

• 35.1 Pimozide Tablet Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Pimozide Tablet Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Pimozide Tablet Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer